Search clinical trials for: PP-001

Total 4112 results

Panoptes Pharma GmbH

Unknown

A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis

Non-infectious Uveitis

Austria, Germany, Belgium, United Kingdom, Netherlands
University of Pennsylvania

Terminated

Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection

Recurrent Clostridium Difficile Infection

United States
Revibe Technologies

Completed

Assessing a Wearable Digital Therapy for Youth With ADHD

ADHD

United States
Panoptes Pharma GmbH

Completed

A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers

Keratoconjunctivitis | Ocular Surface Disease

Austria
Prolong Pharmaceuticals

Completed

Safety Study of PP-007 in Subjects With Acute Ischemic Stroke (HEMERA-1)

Acute Ischemic Stroke

United States
University of Pennsylvania

Terminated

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

Severe Clostridium Difficile Infection | Severe-Complicated/Fulminant Clostridium Difficile Infection

United States
University of Manitoba
Canadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS); The Canadian Collaborative for Childhood Cannabinoid Therapeutics

Not yet recruiting

CANnabinoids in Pediatric ONCology (CAN-PONC)

Cancer | Childhood Cancer
EyeGene Inc.
Novotech (Australia) Pty Limited

Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Prevention of Herpes Zoster (HZ)

Australia
Patagonia Pharmaceuticals, LLC

Completed

A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Congenital Ichthyosis

United States
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Subjects With Asthma

Asthma
PMG Pharm Co., Ltd

Completed

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

Arthritis

Korea, Republic of
Kukje Pharma

Completed

[KSR-001-P01]Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristic of KSR-001

Dry Eye Syndromes

Korea, Republic of
EGEN, Inc.

Terminated

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian Neoplasms

United States
DermBiont, Inc.

Suspended

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

Onychomycosis

United States
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust; Walter Reed Army Institute of Research...

Completed

Sporozoite Challenge of Polyprotein Vaccinees

Malaria | Malaria, Falciparum

United Kingdom
DermBiont, Inc.

Active, not recruiting

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

Tinea Pedis

United States
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Azienda Ospedaliero-Universitaria di Modena; Azienda Unità Sanitaria Locale... and other collaborators

Recruiting

Awake Pronation for Covid-19 Treatment

Covid-19 Infection

Italy
Massachusetts General Hospital

Active, not recruiting

Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: RCT

Metabolic Syndrome

United States
University of Milano Bicocca

Completed

The Prone Position in Covid-19 Affected Patients (PRON-COVID)

Sars-CoV2

Italy
Massachusetts General Hospital

Completed

Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: Proof-of Concept Trial (MAPP-II)

Metabolic Syndrome

United States
UNC Lineberger Comprehensive Cancer Center

Recruiting

Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer Survivors (AYAConnect)

Obesity | Cancer | Physical Activity | Mental Health | Cancer Survivorship

United States
Hvivo
Prep Biopharm Limited

Completed

Study Examining PrEP-001 in Healthy Subjects

Influenza A H3N2

United Kingdom
Ignacio Saez de la Fuente

Completed

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). (OmeLEtte)

Ards

Spain
Pfizer

Completed

A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.

Smoking | Vaccines

Canada
National Cancer Institute (NCI)

Completed

Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection

Head and Neck Cancer | Head and Neck Neoplasms

United States
Temple University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Community-based Obesity Treatment in African American Women After Childbirth

Obesity | Overweight

United States
Universidade Federal de Pernambuco

Completed

Non-invasive Cerebellar Stimulation on Motor Learning

Healthy

Brazil
European Malaria Vaccine Initiative
University of Oxford; Wellcome Trust

Completed

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Malaria | Malaria, Falciparum

United Kingdom
Massachusetts General Hospital
American Diabetes Association

Completed

Boosting Emotions & Happiness in Outpatients Living With Diabetes: Phase I (BEHOLD-16)

Type 2 Diabetes | Emotions | Patient Compliance

United States
Hospices Civils de Lyon

Recruiting

Prone Position in Acute Bronchiolitis (PROPOSITIS)

Acute Viral Bronchiolitis

France
EGEN, Inc.

Completed

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian Neoplasms

United States
101 Therapeutics

Active, not recruiting

Study to Evaluate Pharmacokinetics, Safety & Tolerability of 101-PGC-005 in Healthy, Adult, Human Subjects

Virus Diseases | COVID-19 | Infectious Disease | Glucocorticoids Toxicity

India
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Researching Emotions And Cardiac Health (REACH): Phase II (REACH II)

Emotions | Congestive Heart Failure | Patient Compliance

United States
University of Copenhagen
Göteborg University; University of Aarhus; National Health Insurance foundation; Dan Dental A... and other collaborators

Completed

The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy

Dental Pulp Exposure

Denmark
Alaunos Therapeutics

Completed

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Melanoma

United States
Dr. August Wolff GmbH & Co. KG Arzneimittel
Parexel

Completed

Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients

Dermatitis, Atopic

Germany
TR Therapeutics

Completed

Efficacy Study of GLYC-101 to Evaluate Outcomes After Laser Ablation

Wounds

United States
Massachusetts General Hospital

Recruiting

Promoting Well-being and Health in Heart Failure

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class I

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Positive Psychology for ACS Patients: a Factorial Design Study (PEACEIII)

Acute Coronary Syndrome

United States
NewG Lab Pharma

Active, not recruiting

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Fibrolamellar Carcinoma

Korea, Republic of
Heart and Diabetes Center North-Rhine Westfalia
Martin-Luther-Universität Halle-Wittenberg

Completed

Patient-related Effects of Primary Nursing (ENGAGE)

Nurse's Role

Germany
University of Miami
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process

Chronic Fatigue Syndrome

United States
Antengene Corporation

Terminated

A Study of ATG-010 in Combination With ATG-008 in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (MATCH)

Relapsed/Refractory Diffuse Large B-cell Lymphoma

China
University of Maryland, Baltimore
Agency for Healthcare Research and Quality (AHRQ)

Completed

A Theory-Based Patient Portal eLearning Program for Older Adults With Chronic Illnesses

Chronic Disease | Older Adults | Patient Portals

United States
University of Alexandria

Completed

Laparoscopic Versus Open Repair of Bilateral Primary Inguinal Hernia

Postoperative Complications | Bilateral Inguinal Hernia
EyeGene Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

COVID-19 Vaccine

Australia
Claris Biotherapeutics, Inc.

Recruiting

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars

Corneal Scar

United States
Cryonove Pharma
CEISO; Dermatech; Sefako Makgatho Health Sciences University

Completed

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots.

Solar Lentigo | Post-inflammatory Hyperpigmentation | Senile Lentigo

South Africa
Cryonove Pharma
CEISO; Dermatech; LTD HEALTH

Completed

Tolerance and Performance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

Lentigo Solar

Georgia
National Research Council, Spain
Hospital General Universitario Morales Meseguer

Completed

Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease (FUNGRAPE)

Cardiovascular Diseases

Spain

Search clinical trials for: PP-001

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations